SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-17-030845
Filing Date
2017-08-09
Accepted
2017-08-09 16:36:33
Documents
42
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 501889
2 EXHIBIT 31 ex31.htm EX-31 11882
3 EXHIBIT 32 ex32.htm EX-32 5444
  Complete submission text file 0001140361-17-030845.txt   3184505

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT bstc-20170630.xml EX-101.INS 543029
5 XBRL TAXONOMY EXTENSION SCHEMA bstc-20170630.xsd EX-101.SCH 29485
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bstc-20170630_cal.xml EX-101.CAL 37190
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bstc-20170630_def.xml EX-101.DEF 118684
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstc-20170630_lab.xml EX-101.LAB 438084
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstc-20170630_pre.xml EX-101.PRE 240772
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34236 | Film No.: 171018423
SIC: 2834 Pharmaceutical Preparations